MARC Record from harvard_bibliographic_metadata

LEADER: 04057nam a2200445 a 4500
001 009163009-6
005 20080603165612.0
008 030318s2003 nyua b 101 0 eng
010 $a 2003047451
020 $a0306477629
035 0 $aocm51936842
040 $aDNLM/DLC$cDLC
042 $apcc
050 00 $aRC270.8$b.I5286 2003
060 10 $aQZ 266$bI609n 2003
082 00 $a616.99/406$221
110 2 $aInternational Symposium on Cancer "New Trends in Cancer for the 21st Century"$d(2002 :$cValencia, Spain)
245 10 $aNew trends in cancer for the 21st century /$cedited by Antonio Llombart-Bosch and Vicente Felipo.
260 $aNew York :$bKluwer Academic/Plenum Publishers,$cc2003.
300 $ax, 293 p.$bill. ;$c26 cm.
440 0 $aAdvances in experimental medicine and biology ;$vv. 532
504 $aIncludes bibliographical references and index.
505 0 $aDriving the cell cycle to cancer -- Proliferation: the cell cycle -- Molecular analysis of gene expression in tumor pathology -- Ewing tumor biology: perspectives for innovative treatment approaches -- Cancer epigenetics: DNA methylation and chromatin alterations in human cancer -- Molecular analysis of cancer using DNA and protein microarrays -- Proteomic approaches to the diagnosis, treatment, and monitoring of cancer -- Structural basis of tumoral angiogenesis -- Matrix metalloproteinases and tumor progression -- Angiogenesis inhibitors and their therapeutic potentials -- Mutated tyrosine kinases as therapeutic targets in myeloid leukemias -- Targeting PDGF receptors in cancer: rationales and proof of concept clinical trials -- Immune-promoted tumor cell invasion and metastasis. New considerations -- Improvements of survival in nine phase II clinical studies with different types of cancer upon anti-tumor vaccination with an autologous tumor cell vaccine modified by virus infection to introduce danger signals -- Causation and prevention of solely estrogen-induced oncogenesis: similarities to human ductal breast cancer -- Cyclooxygenase-2 inhibitors in cancer prevention and treatment -- Exosomes for immunotherapy of cancer -- Breast cancer gene expression analysis: the case for dynamic profiling -- Development of the epidermal growth factor receptor inhibitor TARCEVA (OSI-774) -- Gefitinib (IRESSA, ZD 1839) for non-small cell lung cancer (NSCLC): recent results and further strategies -- Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4 -- EORTC research and development: achievements and future perspectives.
520 $aIt is difficult to imagine anyone who has not heard of cancer. This disease can affect families, friends or any one of us at any time in our lives. Every year nearly 3 million Europeans are diagnosed with cancer, leading to around 800,000 deaths per year. These deaths occur not only in aging populations, but also in children and adults who are in the most active period of their lives. This represents a tremendous problem that cannot be ignored by politicians or citizens. Fortunately, there is a constantly growing awareness that although cancer is a problem to be dealt with by clinicians, it should also be the concern of everyone. This volume contains the lectures held at the International Symposium on Cancer "New Trends in Cancer for the 21st Century".
650 0 $aCancer$xMolecular aspects$vCongresses.
650 0 $aCancer$xTreatment$vCongresses.
650 12 $aNeoplasms$ximmunology
650 12 $aNeoplasms$xtherapy
650 22 $aAngiogenesis Inducing Agents$xtherapeutic use
650 22 $aAntineoplastic Agents$xtherapeutic use
655 2 $aCongresses
650 12 $aNeoplasms$ximmunology$vCongresses.
650 12 $aNeoplasms$xtherapy$vCongresses.
650 22 $aAngiogenesis Inducing Agents$xtherapeutic use$vCongresses.
650 22 $aAntineoplastic Agents$xtherapeutic use$vCongresses.
655 7 $aConference proceedings.$2fast
700 1 $aFelipo, Vicente.
700 1 $aLlombart Bosch, Antonio.
988 $a20110721
906 $0OCLC